INS and breast carcinoma: In the study examining the relationship between insulin intake and breast cancer recurrence in diabetic patients, it was observed that the group receiving insulin had a 1.45 (95% CI: 1.19–1.77; P-value <0.001) times higher risk of breast cancer recurrence compared to those not receiving insulin (Fig 2).